Paul Bisaro, Director of Myriad Genetics MYGN, has filed 3 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $179.4K. The latest trade was on 06/04.

PB

PB

Paul Bisaro

Director

Company

Myriad Genetics MYGN

First filing

23/01/05

Trades

43 trades

Buys / sales

3 / 0

12-month net buying

$179.4K

Last trade

06/04

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Myriad GeneticsMYGN	Open-market buy	05/14	05/14	7,500 sh	$3.69	$27,675	+8.3%
ZoetisZTS	Open-market buy	05/13	05/13	2,000 sh	$75.88	$151,760	+7.7%
KT Keenova Therapeutics	Open-market buy	23/03/14	23/03/16	5,000 sh	$8.47	$42,350	+7.2%